Home The Action MC Substitutes/Other Matt Whiteman (UK)

Thu,30Oct2014

Dr. Matt Whiteman

Associate Professor of Experimental Therapeutics
Peninsula Medical School
University of Exeter
St. Luke’s Campus
Magdalen Road
Exeter
Devon EX1 2LU
URL:  http://www.researcherid.com/rid/C-6079-2009
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Interests
My research primarily focuses on the interaction of physiological gases NO, H2S and CO in the vasculature and during inflammatory signalling. In particular I am interested in the development and pharmacological and agricultural potential of novel slow release H2S donor molecules.

Selected Recent Publications

  • Whiteman M, Le Trionnaire S, Chopra M, Fox B, Whatmore J. Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools    Clin Sci (Lond). 2011;121(11):459-88.
  • Fox B, Schantz JT, Haigh R, Wood ME, Moore PK, Viner N, Spencer JP, Winyard PG, Whiteman M. Inducible hydrogen sulfide synthesis in chondrocytes and mesenchymal progenitor cells: is h(2) S a novel cytoprotective mediator in the inflamed joint?  J Cell Mol Med. 2011. doi: 10.1111/j.1582-4934.2011.01357.x
  • Whiteman M, Winyard PG. Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Exp Rev Clin Pharmacol 2011;4(1)13-32.

ESF

COST

POLICY STATEMENT: Biomedicine and Molecular Biosciences Action BM1005 is funded by COST, through its implementing agent the European Science Foundation.